Prot# TMC-BIV-02-08: The ACUITY Trial: A Randomized Comparison of Angiomax® (bivalirudin) vs Heparin (unfractionated heparin or enoxaparin) in Patients Undergoing Early Invasive Management for Acute Coronary Syndromes Without ST-Segment Elevation

Project: Research project

Project Details

StatusFinished
Effective start/end date7/7/0511/25/09

Funding

  • Medicines Company (TMC-BIV-02-08)